SKINSURGICAL
Keloid Removal in Murrieta
Keloid removal is the surgical excision of a keloid scar. The raised fibrous tissue is cut out and the wound is closed under minimal tension, most often as an office procedure under local anesthesia. Because a keloid is itself the product of disordered wound healing, the incision that removes one can seed another, so excision is planned as one half of a combined protocol and paired with an adjuvant such as postoperative radiation therapy or intralesional corticosteroid injection. This is a distinct treatment from keloid injections, which shrink a keloid without removing it.
At a Glance
- Keloid excision performed alone has a reported recurrence rate of 45% to 100%, so it is paired with an adjuvant therapy such as postoperative radiation or intralesional corticosteroid injection[1]
- Surgical excision followed by radiation therapy is reported to recur in approximately 20% of cases, compared with about 37% for radiation therapy alone[2]
- Radiation is most effective when initiated on the same day as the excision, with total doses in the range of 12 to 20 Gy[2]
- Keloids extend beyond the boundary of the original injury, which distinguishes them from hypertrophic scars that stay within the wound margins[1]
- Reported keloid incidence reaches 4.5% to 16% among people with darker skin of African, Asian, and Hispanic descent[1]
Overview
A keloid is a scar that extends past the boundary of the original injury. Fibroblasts in keloid tissue proliferate more, survive longer, and undergo apoptosis at lower rates than in normal healing, and collagen synthesis in the lesion runs about 20 times that of healthy skin, driven largely by dysregulated transforming growth factor-beta signaling. Hypertrophic scars, by comparison, stay within the wound margins and typically do not project more than about 4 millimeters above the skin.
Surgery removes the lesion entirely, which is what makes it attractive for large, pedunculated, symptomatic, or functionally obstructing keloids, and for lesions that have not responded to injection. The recurrence figure is the reason it is never planned alone: excision by itself is reported to recur in 45% to 100% of cases, and patient-facing guidance from the American Academy of Dermatology states that nearly all keloids return after surgery used on its own.
Combining excision with an adjuvant changes that picture substantially. Surgical excision followed by radiation therapy is reported to recur in roughly 20% of cases, compared with about 37% for radiation alone. Radiation is most effective when it begins the same day as the excision, with total doses ranging from 12 to 20 Gy and recent data supporting biologically effective doses above 30 Gy, delivered for example as 13 Gy in one fraction, 16 Gy in two, or 18 Gy in three over five to seven days. Where radiation is not available or not appropriate, intralesional corticosteroid injection is the common adjuvant, and pressure therapy, silicone gel sheeting, and cryosurgery are used alongside it.
Risk is not evenly distributed. Reported incidence reaches 4.5% to 16% in people with darker skin of African, Asian, and Hispanic descent, and rises during puberty and pregnancy. Family history increases susceptibility, though no single causative gene has been identified. The deltoid, presternal chest, upper back, and ears are the sites most often involved, and the chest and trunk carry the highest reported recurrence after treatment at about 34%.
What to expect
- Clinical evaluation of the keloid, including size, site, symptoms, prior treatments, and any personal or family history of keloid formation
- Photography for documentation and comparison at follow-up
- Discussion and selection of the adjuvant protocol before surgery is scheduled, since radiation requires coordinated scheduling
- In some protocols, a series of corticosteroid injections every two to three weeks for about four sessions before the operation
- Preparation and infiltration of local anesthesia at the excision site
- Excision of the keloid, with the margin plan chosen for the site and lesion shape
- Undermining of the wound edges and layered closure designed to eliminate tension
- Same-day initiation of radiation therapy when that adjuvant has been selected, or injection of corticosteroid into the wound margins
- Application of a dressing, with pressure earrings or a compression garment fitted where the site allows
- Suture removal at the interval appropriate to the site, followed by silicone gel sheeting
- Cryosurgery about two weeks after suture removal in protocols that include it
- Scheduled surveillance visits over the following one to two years to catch early regrowth
How a keloid removal works
- Excision removes the keloidal collagen and the overactive fibroblast population contained within the lesion, which is what no topical or injectable treatment can fully accomplish for a large scar.
- Closure is designed for minimal tension. Mechanical tension at the wound edge is a recognized driver of keloid formation, so undermining, deep layered sutures, and orientation along relaxed skin tension lines all serve to reduce the force pulling on the healing scar.
- Removing the lesion also creates a fresh surgical wound in skin that has already demonstrated a keloidal healing response, which is what drives the high recurrence rate after excision alone and why an adjuvant is built into the plan from the start.
- Postoperative radiation works by suppressing the proliferation of fibroblasts in the healing wound during the window when keloid tissue would otherwise begin to form, which is why same-day initiation performs better than delayed treatment.
- Intralesional corticosteroid, used before or after excision, suppresses fibroblast activity and collagen synthesis in the wound bed. Pressure therapy and silicone sheeting act on the maturing scar over months by reducing local blood flow and maintaining hydration of the stratum corneum.
- Site changes the plan more than size does. An earlobe lesion is discrete, its margins are reachable, and the wound can be closed without tension, which is the variable most within a surgeon's control and the one that decides whether a fresh keloid forms in the scar. A lesion spanning the jaw or the neck has none of those advantages, because the skin there is under load every time the head turns. Dr. Banthia examines the lesion and the skin around it before saying whether excision is the right first move at all.
- Because excision alone recurs at a high rate, the adjuvant is settled before a date is set and not after the wound has healed. Which adjuvant, and who delivers it, is decided at the consultation against the lesion's site and size and the patient's own history of keloid formation. Dr. Banthia will also say when the answer is to treat the lesion without cutting it, which for a small keloid is often the better opening move.
When it's recommended
- Large, bulky, or pedunculated keloids that are impractical to treat by injection alone
- Keloids that have not responded to a full course of intralesional corticosteroid injection
- Keloids causing pain, persistent itching, or restricted movement
- Earlobe keloids from piercings, where the lesion is discrete and the margins are accessible
- Keloids that obstruct function, such as a lesion narrowing the ear canal. The same problem at a joint is treated the same way and by a surgeon who operates there; this practice's keloid work is on the face, head, and neck
- Keloids causing significant cosmetic concern where the patient accepts an adjuvant protocol
- Ulcerated, infected, or repeatedly traumatized keloids requiring definitive removal
Is a keloid removal right for you?
Reach out to learn more from Dr. Vishal Banthia.
Recovery & aftercare
- Sutures are typically removed within one to two weeks, with the exact interval depending on the site
- The surgical wound is protected from tension, stretching, and trauma during early healing
- Adjuvant therapy continues on its own schedule after the excision, whether that is radiation, injection, or both
- Pressure earrings or compression garments are worn for extended daily periods over several months where the site allows, and adherence is the main practical challenge
- Silicone gel sheeting is applied to the maturing scar for months after closure
- The scar remains flat and quiet in a successful result, and early thickening, itching, or extension past the incision line is the sign that prompts re-evaluation
- Surveillance continues for one to two years, since recurrence commonly appears within that window
Alternatives
- Intralesional corticosteroid injection alone, the first-line nonsurgical treatment, which softens and flattens a keloid without removing it
- Cryotherapy, used alone for small lesions or combined with injection
- Silicone gel sheeting or silicone-based scar products
- Pressure therapy with compression garments or pressure earrings
- Laser treatment to flatten the lesion and reduce redness, often combined with injection
- Radiation therapy alone, which carries a reported recurrence rate of about 37%
- Observation, with prevention of further elective trauma to keloid-prone skin
Related treatments
Frequently Asked Questions
- Keloid removal is the surgical excision of a keloid scar. The raised fibrous tissue is cut out and the wound is closed with as little tension as possible, usually under local anesthesia in an office setting. It is planned together with an adjuvant treatment, because excision on its own has a high rate of regrowth.
- Keloid injections deliver corticosteroid into the lesion to soften and flatten it over a series of sessions, leaving the scar tissue in place. Keloid removal excises the lesion surgically. Injection is the first-line nonsurgical approach and is often used before, after, or in place of surgery; excision is reserved for large, symptomatic, obstructing, or injection-resistant keloids, and it is always combined with an adjuvant such as radiation or injection.
- Recurrence is the central risk. Excision alone is reported to recur in 45% to 100% of cases, and published patient guidance describes nearly all keloids as returning after surgery used on its own. Pairing excision with radiation brings reported recurrence down to roughly 20%; pairing it with intralesional corticosteroid, pressure therapy, or cryosurgery is the common alternative where radiation is not suitable. Dr. Banthia settles which of those the plan uses before a date is set, so a patient consents knowing the number rather than meeting it afterwards.
- The incision that removes a keloid is itself a fresh wound in skin that has already shown a keloidal healing response. Adjuvant therapy targets that window: radiation suppresses fibroblast proliferation in the healing wound and is most effective when started the same day as surgery, while corticosteroid injection, pressure, and silicone sheeting act on the maturing scar over the following months.
- Sutures typically come out within one to two weeks depending on the site, and the wound is protected from tension and trauma while it heals. Adjuvant treatment continues afterward on its own schedule, and pressure earrings or garments may be worn for extended daily periods over several months. Follow-up continues for one to two years, since regrowth usually appears within that window.
- Excision is generally deferred when there is active infection at the site, when the wound could not be closed without tension, when a bleeding disorder or anticoagulation is unmanaged, or when the patient is unable to complete the adjuvant course that follows. Pregnancy is a reason to avoid protocols that use radiation. Small keloids that have not yet been treated with injection are usually managed nonsurgically first.
- By where it stops. A hypertrophic scar stays inside the boundary of the original wound and usually settles over a year or two; a keloid grows past that boundary and does not settle on its own. The distinction changes the whole plan, which is why Dr. Banthia makes it at the examination – an ordinary raised scar is treated as scar revision, a different operation with a different recurrence profile.
- The earlobe is the commonest site a facial surgeon sees, usually after a piercing, and its margins make it one of the more approachable lesions to excise cleanly. Dr. Banthia removes them with the adjuvant plan settled in advance, and will discuss whether re-piercing is advisable afterwards, which for keloid-prone skin it frequently is not.
- Keloid Removal may not be appropriate for individuals with active infection at or around the lesion or unwillingness or inability to complete the adjuvant therapy that follows excision. Possible side effects include recurrence of the keloid, which is the principal risk and is reported in 45% to 100% of cases after excision alone, recurrence at a larger size than the original lesion, wound dehiscence, particularly where closure was under tension. Dr. Banthia will review your health history to ensure Keloid Removal is safe for you.
- Consultations for keloid removal are available at Dr. Banthia's Murrieta office (39755 Date St, Suite 105, Murrieta, CA 92563); Dr. Banthia's Carlsbad office (2390 Faraday Ave, Carlsbad, CA 92008). Contact the office to schedule an appointment at the location most convenient for you.
Keloid Removal risks & candidacy
Who should avoid this
- Active infection at or around the lesion
- Unwillingness or inability to complete the adjuvant therapy that follows excision
- Bleeding disorders or anticoagulant therapy without medical clearance
- A wound that could not be closed without tension, since tension drives recurrence
- Active tobacco or nicotine use, which impairs wound healing at the closure
- Uncontrolled diabetes or another condition that impairs wound healing
- Pregnancy, when the planned adjuvant is radiation therapy
Possible risks
- Recurrence of the keloid, which is the principal risk and is reported in 45% to 100% of cases after excision alone
- Recurrence at a larger size than the original lesion
- Wound dehiscence, particularly where closure was under tension
- Infection at the surgical site
- Bleeding or hematoma
- Hypopigmentation or hyperpigmentation of the treated skin
- Skin atrophy and telangiectasia from corticosteroid used as an adjuvant
- Erythema and pigmentary change from adjuvant radiation, reported in roughly 30% of irradiated patients
- Rare serious complications of adjuvant radiation, reported in under 1% of patients
- Contour irregularity or deformity at the site, particularly on the earlobe
- Pain or altered sensation at the scar
Your practitioner
Dr. Vishal Banthia, MD, FACS
Dr. Vishal Banthia is a double board-certified facial plastic surgeon practicing in Murrieta and Carlsbad, California. He is certified by the American Board of Facial Plastic and Reconstructive Surgery and the American Board of Otolaryngology-Head and Neck Surgery, and is a Fellow of the American College of Surgeons. His practice is surgical and face-only: facelift, neck lift, eyelid surgery, and rhinoplasty. He lectures internationally, has published peer-reviewed research indexed in the National Library of Medicine, and received the American Academy of Otolaryngology's Humanitarian Travel Award for cleft lip and palate surgery in Honduras.
Sources & references
This article draws on 4 sources, including peer-reviewed research, leading medical institutions.
Government & research
Medical institutions
Educational & general
Medically reviewed by Dr. Vishal Banthia, MD, FACS · Last reviewed: 2026-08-08